. 2011 Sep 2;2(6):1261–1267. doi: 10.3892/ol.2011.409

Table IV.

MIF serum concentrations.

Group	N	χ̄±s (ng/ml)	P-value
Controls	48	11.24±1.86
Patients	102	16.31±5.07	0.000^a
Lymphatic metastasis	21	23.88±5.03	0.002^b	0.000^d
No lymphatic metastasis	81	14.34±2.69	0.000^c
Well-differentiated	19	11.40±1.70	0.000^e
Moderately differentiated	57	16.30±3.48	0.000^f
Poorly differentiated	26	19.92±6.55	0.000^g

Statistically significant difference between average MIF concentrations in

^{^a}

controls and patients;

^{^b}

controls and patients with lymphatic metastasis;

^{^c}

controls and patients without lymphatic metastasis;

^{^d}

patients with and without lymphatic metastasis;

^{^e}

well and moderately differentiated groups;

^{^f}

well and poorly differentiated groups; and

^{^g}

moderately and poorly differentiated groups; (P<0.05), for all concentrations.